Cancer Vaccines
New data illuminates research in Cancer Vaccines
Published in Blood Weekly, January 12th, 2006
Study 1: An epitope derived from the cancer testis antigen HOM-TES-14/SCP1 was presented by dendritic cells to circulating CD4+ T cells.
"Because of their frequent expression in a wide spectrum of malignant tumors but not in normal tissue except testis, cancer testis antigens are promising targets. However, except for HOM-TES-14/SCP1, their expression in malignant lymphomas is rare."
"SCP1 (synaptonemal complex protein 1) has been shown to elicit antibody responses in the autologous host, but no T-cell responses against HOM-TES-114/SCP1 have been...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-01-12)
More Articles from Blood Weekly
- Cord Blood
Unrelated cord blood transplant successful in children with Shwachman-Diamond syndrome - Liver Regeneration
Partial hepatectomy induces mobilization of stem cells in healthy liver donors - Stem Cell Research
Antibody-conjugated magnetoliposomes rapidly and efficiently expand mesenchymal stem cells - Tissue Engineering
Keratinocytes and dermal fibroblasts cultured on PLGA microspheres regenerates skin - Tissue Engineering
Pulsed low intensity ultrasound stimulates intervertebral disc cell cellular metabolism - Acute Lymphoblastic Leukemia
European study confirms efficacy of clofarabine in pediatric patients with ALL - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
